Apollo Endosurgery Inc (APEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Summary

Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The companys product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and Lap-Band system for laparoscopic bariatric surgeries. These surgical and non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endos products are used by bariatric surgeons, general surgeons and gastroenterologists. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endo is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc (APEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 3
List of Figures 4
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Apollo Endosurgery Inc, Medical Devices Deals, 2011 to YTD 2017 9
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 11
Equity Offering 12
Apollo Endosurgery to Raise up to USD26.1 Million in Public Offering of Shares 12
Lpath Raises USD12.5 Million in Private Placement of Shares 13
Lpath Files Registration Statement For Public Offering Of Class A Common Stock For Up To US$20 Million 15
Lpath Files Registration Statement For Public Offering Of Securities For Up To US$40 Million 15
Lpath Completes Public Offering Of Shares For US$12 Million 16
Lpath Announces Public Offering Of Class A Common Stock For US$9.3 Million 17
Asset Transactions 18
Pfizer Plans To Sell Certain Ohthalmology R&D Assets 18
Apollo Endosurgery Inc - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Strategy And Business Planning 23
Jan 19, 2016: Leading Medical Device Companies Select Brainshark to Drive Sales Productivity 23
Financial Announcements 24
Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 24
May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 25
Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 26
Corporate Communications 28
Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 28
Product News 29
Jun 20, 2016: Lpath Awarded Department of Defense Grant for Traumatic Brain Injury Pain Study 29
Clinical Trials 30
Apr 19, 2016: Lpath Reports Favorable Results from Phase 1 Study of Lpathomab 30
Feb 01, 2016: Lpath Completes Dosing in the Lpathomab Phase 1 Safety Study 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables


Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apollo Endosurgery Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Apollo Endosurgery Inc, Medical Devices Deals, 2011 to YTD 2017 9
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 11
Apollo Endosurgery to Raise up to USD26.1 Million in Public Offering of Shares 12
Lpath Raises USD12.5 Million in Private Placement of Shares 13
Lpath Files Registration Statement For Public Offering Of Class A Common Stock For Up To US$20 Million 15
Lpath Files Registration Statement For Public Offering Of Securities For Up To US$40 Million 15
Lpath Completes Public Offering Of Shares For US$12 Million 16
Lpath Announces Public Offering Of Class A Common Stock For US$9.3 Million 17
Pfizer Plans To Sell Certain Ohthalmology R&D Assets 18
Apollo Endosurgery Inc, Key Competitors 20
Apollo Endosurgery Inc, Key Employees 21
Apollo Endosurgery Inc, Other Locations 22
Apollo Endosurgery Inc, Subsidiaries 22

List Of Figures


Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Apollo Endosurgery Inc, Medical Devices Deals, 2011 to YTD 2017 9

Pharmacies and Healthcare Stores Global Market Forecast To 2022 Including: Pharmacies and Drug Stores, Other Health and Personal Care Stores Covering: MedPlus, Medzone, Medicap, Apollo Pharmacy, Discount Drug Stores

The pharmacies and healthcare stores market consists of sales of pharmacy and healthcare store products and related services by entities (organizations, sole traders and partnerships) that operate pharmacies and other

USD 4000 View Report

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a healthcare service provider that offers a range of healthcare services. It offers healthcare services, clinical and diagnostic services, medical business process outsourcing,

USD 250 View Report

Apollo Endosurgery Inc (APEN) - Financial and Strategic SWOT Analysis Review

Apollo Endosurgery Inc (APEN) - Financial and Strategic SWOT Analysis Review

USD 125 View Report

Apollo Endosurgery Inc (LPTN) - Medical Equipment - Deals and Alliances Profile

Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, discovers and develops monoclonal antibodies that target bioactive lipids. It develops lipidomic-based therapeutic antibodies that target bioactive signaling lipids to treat a

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available